1. Whitaker, B. I., & Hinkins, S. (2011). The 2011 National blood collection and utilization survey report. Retrieved July 27, 2015, from
http://www.aabb.org/research/hemovigilance/bloodsurvey/Documents/11-nbcus-report.pdf
.
2. Centers for Disease Control and Prevention (CDC). (1991). Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR,
40(RR-4), 1–17.
3. U. S. Food and Drug Administration. (2015). Complete list of donor screening assays for infectious agents and HIV diagnostic assays. 2015, from
http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM080466
.
4. Brown, L. K., Whiteley, L., Harper, G. W., Nichols, S., Nieves, A., & Protocol Team for The Adolescent Medicine Trials Network for HIV/AIDS Interventions. (2015). Psychological symptoms among 2032 youth living with HIV: A multisite study. AIDS Patient Care STDS,
29(4), 212–219.
5. Honiden, S., Sundaram, V., Nease, R. F., Holodniy, M., Lazzeroni, L. C., Zolopa, A., et al. (2006). The effect of diagnosis with HIV infection on health-related quality of life. Quality of Life Research,
15(1), 69–82.